Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Citations 0
Special Feature
February 2001

Image of the Month

Author Affiliations



Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001

Arch Surg. 2001;136(2):240. doi:
Answer: Toxic Adenoma or Solitary Autonomous Nodule (Variant of Plummer Disease)

Figure 1. Radionuclide scan demonstrates a "hot" nodule in the right lobe of the thyroid gland with suppression of all remaining thyroid tissue.

Figure 2."Hot" nodule. Treatment was a right thyroid lobectomy.

Palpable solitary thyroid nodules are present in approximately 5% to 6% of American women, a rate that is at least 4 times greater than that noted in men in several studies.1 Despite the small number of patients who develop thyroid cancer in the United States each year (estimated 18 400 in 2000), many thyroidectomies in the past were performed to rule out a malignant tumor in such nodules.2 The availability of early and accurate diagnosis from FNA, however, has significantly decreased unnecessary thyroidectomies for benign nodules over the past 25 years.3,4 At present, indications for operation in patients with solitary thyroid nodules include the following:

  • Nondiagnostic (15%-20%) or suspicious (10%) FNA

  • Malignant cells on FNA (4%)

  • Growth of nodule (use ultrasound to rule out hemorrhage into the nodule) in patient receiving thyroxine therapy

  • Symptomatic (pain, tracheal deviation with respiratory symptoms, odynophagia) nodule in patient without evidence of hemorrhage into the nodule

  • Patient request to improve cosmetic appearance

  • Toxic (hyperfunctioning) adenoma

Clinical hyperthyroidism from a hyperfunctioning adenoma develops gradually over time. Asymptomatic patients with reasonably normal TSH levels associated with an FNA-benign nodule can be observed according to a standard endocrinology textbook. When TSH levels fall below normal levels and the patient is symptomatic, current therapeutic options for a toxic adenoma include antithyroid drugs, radioactive iodine, percutaneous injection of ethanol, and thyroidectomy.5

Antithyroid drugs have the disadvantage of recurrent hyperthyroidism when administration is stopped, but they have been used before administration of radioactive iodine or thyroidectomy in elderly patients. Radioactive iodine should be taken up by the hyperfunctioning nodule when the remainder of the thyroid gland is suppressed (Figure 1). Five to 15 mCi 131 I should result in a cure rate of 90% in elderly patients.6,7 Multiple percutaneous injections of sterile 95% ethanol into the toxic adenoma with ultrasonography resulted in a cure rate of 78% in an Italian study (median follow-up, 2.5 years).8

Toxic adenomas are the third most common indication for surgical intervention for hyperthyroidism.9,10 Depending on local referral patterns to endocrine surgeons, operations for toxic adenoma account for 5% to 20% of current operations for hyperthyroidism. Thyroidectomy is generally recommended for children, adults, and should be considered for otherwise healthy elderly patients with large nodules. Most patients referred from endocrinologists return to a euthyroid state by the administration of antithyroid drugs. Preoperative administration of a saturated solution of potassium iodide is unnecessary. Either nodulectomy or subtotal vs total thyroid lobectomy can be performed (Figure 2). Thyroidectomy is immediately curative in patients who are euthyroid at the time of operation. Postoperative and late rates of hypothyroidism are reported to be 10% to 20% in the medical literature.7,11

Back to top
Article Information

Corresponding author: David V. Feliciano, MD, Grady Memorial Hospital, Thomas K. Glenn Memorial Bldg, Department of Surgery, 69 Butler St SE, Third Floor, Atlanta, GA 30303.

Vander  JBGaston  EADawber  TR The significance of nontoxic thyroid nodules. Ann Intern Med. 1968;69537- 540Article
Greenlee  RTMurray  TBolden  SWingo  PA Cancer statistics, 2000. Cancer. 2000;507- 33
Einhorn  JFranzen  S Thin needle biopsy in the diagnosis of thyroid disease. Acta Radiol (Stockh). 1962;58321- 336Article
Gharib  HGoellner  JR Fine-needle aspiration of the thyroid: an appraisal. Ann Intern Med. 1993;118282- 289Article
Hermus  ARHuysmans  DA Treatment of benign nodular thyroid disease. N Engl J Med. 1998;3381438- 1447Article
Larsen  PRDavies  TFHay  ID The thyroid gland. Wilson  JDFoster  DWKronenberg  HMLarsen  PReds.Williams' Textbook of Endocrinology. 9th ed. Philadelphia, Pa WB Saunders Co1998;389- 515
Giuffrida  DGharib  H Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med. 1995;99642- 650Article
Monzani  FCaraccio  NGoletti  O  et al.  Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Clin Endocrinol. 1997;469- 15Article
Graves  RJ Newly observed affection of the thyroid gland in females. London Med Surg J. 1835;7 ((part 2)) 516- 517
Plummer  HS The clinical and pathological relationship of simple and exophthalmic goitre. Trans Assoc Am Physicians. 1913;28587- 594
Ferrari  CReschini  EParacchi  A Treatment of the autonomous thyroid nodule: a review. Eur J Endocrinol. 1996;135383- 390Article